IKSI: 2nd International Urolithiasis Research Symposium

Information

  • Research Project
  • 7540831
  • ApplicationId
    7540831
  • Core Project Number
    R13DK082083
  • Full Project Number
    1R13DK082083-01
  • Serial Number
    82083
  • FOA Number
    PA-06-41
  • Sub Project Id
  • Project Start Date
    4/1/2008 - 16 years ago
  • Project End Date
    3/30/2009 - 15 years ago
  • Program Officer Name
    RASOOLY, REBEKAH S.
  • Budget Start Date
    4/1/2008 - 16 years ago
  • Budget End Date
    3/30/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/6/2008 - 16 years ago

IKSI: 2nd International Urolithiasis Research Symposium

[unreadable] DESCRIPTION (provided by applicant): [unreadable] [unreadable] A generation ago, the management of patients with symptomatic stones was forever dramatically altered with the introduction of minimally invasive treatment such as shock wave lithotripsy, ureteroscopy and precutaneous stone removal. After many years of incremental improvements, the field of urolithiasis is on the cusp of, again, revolutionary discoveries in the management and prevention of kidney stone disease. In addition, there has been very few major international meeting that have focused on the new clinical and basic science discoveries in this field. To address this need the International Kidney Stone Institute (IKSI) held the 1st International Urolithiasis Research symposium in November of 2006 and addressed the clinical and basic science aspects of both kidney pathogenesis and treatment. Because of the overwhelming success of the 1st International Urolithiasis Research symposium, IKSI has organized and will host the "2nd International Urolithiasis Research symposium" in Indianapolis, Indiana on April 17-18, 2008. This meeting will bring together about fifth clinical and basic science experts from around the globe to: 1) address the latest findings in nephrolithiasis, 2) examine the a select group of state-of-the-art techniques that appear to have the potential to rapidly advance our understanding of how stone from and grow and 3) provide an scientific atmosphere to stimulate and challenge students and junior faculty members to consider a career in kidney stone disease. Another feature of this symposium is that a number of international scientists that have never participated in a symposium together will discuss kidney stone disease from their area of expertise. Finally, because the clinical and basic science topics relevant to kidney stone disease cross a number of disciplines, no one society has covered this field completely at their annual meeting. Therefore, in our view, there appears to be a critical need in the field of nephrolithiasis for a comprehensive international meeting that is conducted on a regular basis so that new data and ideas can be easily and rapidly shared with the goal of improving care for all kidney stone patients. This assumption was supported by the great success of the 1st International Urolithiasis Research symposium and the high level of interest in the 2nd symposium date. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R13
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    10000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:10000\
  • Funding Mechanism
  • Study Section
    ZDK1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CLARIAN HEALTH PARTNERS, INC.
  • Organization Department
  • Organization DUNS
    965248321
  • Organization City
    INDIANAPOLIS
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    462061367
  • Organization District
    UNITED STATES